Literature DB >> 22469197

Duration and compliance with antidepressant treatment in immigrant and native-born populations in Spain: a four year follow-up descriptive study.

Inés Cruz1, Catalina Serna, Montserrat Rué, Jordi Real, Jorge Soler-Gonzalez, Leonardo Galván.   

Abstract

BACKGROUND: Non-compliance with antidepressant treatment continues to be a complex problem in mental health care. In immigrant populations non-compliance is one of several barriers to adequate management of mental illness; some data suggest greater difficulties in adhering to pharmacological treatment in these groups and an increased risk of therapeutic failure. The aim of this study is to assess differences in the duration and compliance with antidepressant treatment among immigrants and natives in a Spanish health region.
METHODS: Population-based (n = 206,603), retrospective cohort study including all subjects prescribed ADT between 2007 and 2009 and recorded in the national pharmacy claims database. Compliance was considered adequate when the duration was longer than 4 months and when patients withdrew more than 80% of the packs required.
RESULTS: 5334 subjects (8.5% of them being immigrants) initiated ADT. Half of the immigrants abandoned treatment during the second month (median for natives = 3 months). Of the immigrants who continued, only 29.5% presented good compliance (compared with 38.8% in natives). The estimated risk of abandoning/ending treatment in the immigrant group compared with the native group, adjusted for age and sex, was 1.28 (95%CI 1.16-1.42).
CONCLUSIONS: In the region under study, immigrants of all origins present higher percentages of early discontinuation of ADT and lower median treatment durations than the native population. Although this is a complex, multifactor situation, the finding of differences between natives and immigrants in the same region suggests the need to investigate the causes in greater depth and to introduce new strategies and interventions in this population group.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469197      PMCID: PMC3350418          DOI: 10.1186/1471-2458-12-256

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  17 in total

1.  Continuity of antidepressant treatment for adults with depression in the United States.

Authors:  Mark Olfson; Steven C Marcus; Michael Tedeschi; George J Wan
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.

Authors:  Walid F Gellad; Jennifer S Haas; Dana Gelb Safran
Journal:  J Gen Intern Med       Date:  2007-09-20       Impact factor: 5.128

3.  Comparative exposure to antipsychotic medications in immigrant and native-born populations of a Spanish health region.

Authors:  I Cruz; C Serna; M Rué; J Real; L Galván; J Pifarré
Journal:  Eur Psychiatry       Date:  2011-05-12       Impact factor: 5.361

4.  Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration.

Authors:  Dominique Milea; Florent Guelfucci; Nawal Bent-Ennakhil; Mondher Toumi; Jean-Paul Auray
Journal:  Clin Ther       Date:  2010-11       Impact factor: 3.393

5.  Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics.

Authors:  Dorte Gilså Hansen; Werner Vach; Jens-Ulrik Rosholm; Jens Søndergaard; Lars F Gram; Jakob Kragstrup
Journal:  Fam Pract       Date:  2004-11-01       Impact factor: 2.267

6.  Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database.

Authors:  M C Serna; I Cruz; J Real; E Gascó; L Galván
Journal:  Eur Psychiatry       Date:  2009-12-14       Impact factor: 5.361

7.  Role of patient experience in antidepressant adherence: a retrospective data analysis.

Authors:  Mark Vanelli; Marcelo Coca-Perraillon
Journal:  Clin Ther       Date:  2008-09       Impact factor: 3.393

8.  Explaining patients' beliefs about the necessity and harmfulness of antidepressants.

Authors:  James E Aikens; Donald E Nease; Michael S Klinkman
Journal:  Ann Fam Med       Date:  2008 Jan-Feb       Impact factor: 5.166

9.  Patterns of antidepressant use in community practice.

Authors:  G E Simon; M VonKorff; E H Wagner; W Barlow
Journal:  Gen Hosp Psychiatry       Date:  1993-11       Impact factor: 3.238

10.  Initiation of antidepressant therapy: do patients follow the GP's prescription?

Authors:  Erica C G van Geffen; Helga Gardarsdottir; Rolf van Hulten; Liset van Dijk; Antoine C G Egberts; Eibert R Heerdink
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

View more
  3 in total

1.  Barriers to and Correlates of Retention in Behavioral Health Treatment Among Latinos in 2 Different Host Countries: The United States and Spain.

Authors:  Irene Falgas; Zorangeli Ramos; Lizbeth Herrera; Adil Qureshi; Ligia Chavez; Covadonga Bonal; Samantha McPeck; Ye Wang; Benjamin Cook; Margarita Alegría
Journal:  J Public Health Manag Pract       Date:  2017 Jan/Feb

2.  Antidepressant utilization after hospitalization with depression: a comparison between non-Western immigrants and Danish-born residents.

Authors:  Helle Wallach-Kildemoes; Louise Thirstrup Thomsen; Margit Kriegbaum; Jørgen Holm Petersen; Marie Norredam
Journal:  BMC Psychiatry       Date:  2014-03-17       Impact factor: 3.630

3.  Antidepressant adherence and its predictors in immigrants with depression: A population-based study.

Authors:  Suhyun Jang; Hyemin Cho; Cinoo Kang; Sunmee Jang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.